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Abstract
Background: Why does a tumor start where it does within an organ? Location is
traditionally viewed as a random event, yet the statistics of the location of tumors
argues against this being a random occurrence. There are numerous examples
including that of breast cancer. More than half of invasive breast cancer tumors start
in the upper outer quadrant of the breast near the armpit, even though it is
estimated that only 35 to 40% of breast tissue is in this quadrant. This suggests that
there is an unknown microenvironmental factor that significantly increases the risk of
cancer in a spatial manner and that is not solely due to genes or toxins. We
hypothesize that tumors are more prone to form in healthy tissue at microvascular
‘hot spots’ where there is a high local concentration of microvessels providing an
increased blood flow that ensures an ample supply of oxygen, nutrients, and
receptors for growth factors that promote the generation of new blood vessels.
Results: To show the plausibility of our hypothesis, we calculated the fractional
probability that there is at least one microvascular hot spot in each region of the
breast assuming a Poisson distribution of microvessels in two-dimensional cross
sections of breast tissue. We modulated the microvessel density in various regions of
the breast according to the total hemoglobin concentration measured by near
infrared diffuse optical spectroscopy in different regions of the breast. Defining a hot
spot to be a circle of radius 200 μm with at least 5 microvessels, and using a
previously measured mean microvessel density of 1 microvessel/mm2, we find good
agreement of the fractional probability of at least one hot spot in different regions of
the breast with the observed invasive tumor occurrence. However, there is no reason
to believe that the microvascular distribution obeys a Poisson distribution.
Conclusions: The spatial location of a tumor in an organ is not entirely random,
indicating an unknown risk factor. Much work needs to be done to understand why
a tumor occurs where it does.
Keywords: Breast cancer, Anatomical tumor distribution, Vasculature, Upper outer
quadrant
Background
The question of tumor location: Why does a tumor occur where it does?
While the location of a tumor in an organ is often viewed as random, the statistics of
the anatomical distribution of tumors indicates that tumor location is not random in
the sense that the probability that a tumor will occur in a given region is not propor-
tional to the volume of that region of the organ. For example, more than half of
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invasive breast tumors occur in the upper outer quadrant of the breast near the armpit
(Morris & Kwong, 2004) (see below). Lung tumors occur more than twice as often in the
upper lobe compared to the lower lobe of the lung even though the upper and lower lobes
have roughly the same volume (Byers et al., 1984). Examination of tissue from prophylactic
oophorectomies from women at high risk for ovarian cancer finds that microscopic cancer
most commonly occurs in the fimbrae (Crum et al., 2007), i.e., the distal portion of the fallo-
pian tubes near the ovaries, even though the fallopian tubes are histologically the same
along their entire length. If we divide the colon at the splenic flexure into a proximal and a
distal section (and exclude the rectum), colon cancer tends to be found in the proximal, ra-
ther than in the distal, part of the colon even though these two sections are roughly the
same length. SEER (Surveillance, Epidemiology, and End Results) data (Siegel et al., 2014)
from 2006 to 2010 indicates that 42% of the cases of colon cancer occurred in the proximal
colon compared to 23% in the distal colon. The rest (28%) occurred in the rectum. It should
be noted that the proximal and distal colon differ in terms of development (embryology),
physiology, and molecular biology (Gervaz et al., 2004) but it is not clear whether any of
these differences can account for the preference of tumors to occur in the proximal colon.
So why does a tumor occur where it does? The lack of randomness in the anatomical dis-
tribution of tumors in various organs suggests that there is an unknown microenvironmen-
tal factor that significantly increases the risk of cancer in a spatial manner. Though it has
largely been ignored, this question is important since it implies that it is not simply genes or
toxins that promote tumor initiation preferentially in some regions of a given organ.
In this paper, we propose that the microvessel density could be a predisposing factor. Our hy-
pothesis is that tumors are prone to develop where there is a high concentration of blood flow
that can supply ample oxygen and nutrients to the tumor. We will refer to such regions with a
high concentration of microscopic blood vessels as ‘microvascular hot spots’. We will use the
breast as an example to discuss our proposition that local variations in the microvascular dens-
ity could account for the increased tumor incidence in the upper outer quadrant. (A review of
this paper with more introductory material is contained in a review article that will appear in
Reports on Progress in Physics. The review article is by the same authors as this paper and is en-
titled “The Physical Location of Incipient Cancer: Why Does a Tumor Start Where It Does?”)
Breast tumors occur most frequently in the upper outer quadrant
Since the rest of this article will focus on the occurrence of breast tumors in the upper
outer quadrant, we will begin with a brief introduction to the breast (Schnitt & Collins,
2018; Love et al., 2015) and breast cancer. The function of the mammary gland is to
produce milk. Milk is produced in small grapelike sacs called acini. A cluster of acini is
called a lobule and a cluster of lobules is called a lobe. The milk produced in acini flows
into a small channel called a ductule. Ductules merge to form milk ducts. Each lobe
has one milk duct. If you look at the cross-section of a milk duct (see Fig. 1), it is lined
with mammary epithelial cells. Surrounding the mammary epithelial cells is a layer of
myoepithelial cells that help to squeeze the milk down the duct. Outside the myoe-
pithelial cells is a tough outer sheath called the basement membrane. It is an example
of extracellular matrix and is composed of proteins such as collagen.
Most breast tumors start in the milk ducts or lobules. Typically the mammary
epithelial cells start to proliferate and fill up the luminal space in the duct or acini.
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When they do this to a substantial degree, this is known as ductal carcinoma in
situ. This is stage zero cancer. The phrase “in situ” literally means “in place”. In
this case, it means that the cells have not broken through the basement membrane.
If the epithelial cells continue to proliferate and break out of the duct and through
the basement membrane, then this is called invasive ductal carcinoma. “Invasive”
means that the cells have invaded tissue where they do not belong.
Analysis of the data for the location of invasive tumors from approximately 137,000 California
female breast cancer patients between 1988 and 1999 reveals that 57% of these tumors occur in
the upper outer quadrant (UOQ) of the breast near the armpit (Morris & Kwong, 2004). The
three other quadrants and the central/areolar/nipple region each account for 15% or less of the
tumors as shown in Table 1. If the location of breast tumors were random, then we would ex-
pect the probability of a tumor to occur in a region to be proportional to the volume of that re-
gion. However, the UOQ certainly does not contain more than half of the breast tissue.
If one considers different types of breast cancer, then almost all types of breast tu-
mors occur most frequently in the upper outer quadrant as shown in Fig. 2. The only
exception is Paget’s disease which is a type of cancer of the nipple.
Methods
Hypothesis: Tumors preferentially form in regions with high microvascular density
Tumors must have blood vessels supplying oxygen and other nutrients if they are to grow be-
yond a few cubic millimeters. (However, the lack of oxygen, a condition known as hypoxia,
Fig. 1 Cross section of a normal milk duct showing the lumen, mammary epithelial cells, myoepitheial cells,
and basement membrane
Table 1 Location of invasive breast tumors. Data from 137,000 California female beast cancer
patients between 1988 and 1999 (Morris & Kwong, 2004). These include stage 1 and higher stages
as well as different types of breast cancer
Upper Outer Upper Inner Lower Outer Lower Inner Nipple, Areola
57% 15% 10% 8% 11%
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can also promote tumor growth. Possible mechanisms for how hypoxia could promote
tumor growth include impeding the immune system, selecting for hardier cancer cells that
can resist radiation and chemotherapy drugs, and encouraging cancer cells to migrate and in-
vade other tissues (Jain, 2014; Blagosklonny, 2004)). Since oxygen only diffuses 100–150 μm
(Fidler et al., 2002; Gray et al., 1953; Tannock, 1968; Brown & Giaccia, 1998; Thomlinson &
Gray, 1955), and cytokines like vascular endothelial growth factor (VEGF) diffuse even less
due to their size, there must be microvessels within this distance of an incipient tumor. More
tissue in the UOQ means more microvessels near which tumors could grow. However, as-
suming uniform perfusion, the fraction of microvessels in the UOQ should be proportional
to the fraction of tissue in that quadrant. So if 35–40% of the tissue is in the upper outer
quadrant, then 35–40% of the vasculature (and tumors) should be in the UOQ. However,
perfusion is not uniform as indicated by optical measurements (Parbhoo & Seifalian, 1998;
Shah et al., 2004; Svensson et al., 2005). Both laser Doppler imaging (Parbhoo & Seifalian,
1998), which measures the skin blood flow, and near infrared diffuse optical spectroscopy
(DOS) measurements (Shah et al., 2004; Svensson et al., 2005), which penetrates into the tis-
sue and can measure total hemoglobin concentration in a volume of about 10 cm3, find vari-
ations in the blood flow between different quadrants of the breast as well as the areolar
region. However, prima facie, these variations do not appear to be large enough to account
for the preponderance of tumor incidence in the UOQ.
Our hypothesis is that incipient tumors preferentially tend to form at ‘microvascular
hot spots’ that correspond to small regions of tissue with a high concentration of
microvessels. We hypothesize that perhaps small incipient tumors are more likely to
flourish and be vascularized if they are located at “microvascular hot spots” where there
is a particularly high density of microvessels. We are referring to hot spots present in
disease-free/cancer-free tissue that has not been remodeled by proliferating neoplastic
tissue (Carpenter et al., 2011).
Fig. 2 Anatomical site distribution of different types of breast tumors (Morris & Kwong, 2004). Note that almost
all types of tumors occur most frequently in the upper outer quadrant (UOQ) with the exception of Paget’s
disease (PD) which corresponds to nipple cancer. UIQ = upper inner quadrant, LIQ = lower inner quadrant and
LOQ = lower outer quadrant. DC = ductal carcinoma, LC = lobular carcinoma, DLC = ductal lobular carcinoma,
CC = comedocarcinoma, MMA =mucinous and mucin-producing adenocarcinoma, MC=medullary carcinoma,
IC = inflammatory carcinoma, TC = tubular carcinoma, and PA = papillary adenocarcinoma
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We would like to calculate the probability of such hot spots in the different quadrants to
see if there is a higher probability for such hot spots in the upper outer quadrant, and to de-
termine if this higher probability is consistent with the higher incidence of tumors in this
quadrant. Unfortunately, there are no measurements of the microvascular distribution in the
breast, nor have there been measurements of the fraction of breast tissue in each quadrant.
However, as a simple example of such a calculation, we will imagine two-dimensional (2D)
cross sections of tissue that have been stained to reveal microvessels as discrete points. Our
goal is to calculate the probability Q that at least one hot spot occurs in a region of surface
area A. To illustrate our method of calculation, consider marking a spot on a table, drawing a
circle of radius R centered at the spot, sprinkling salt on the table and asking what is the
probability P that at least n grains of salt are within the circle. The larger the number of
grains required to be in the circle, the smaller the probability of a small circle enclosing that
many grains of salt. Suppose we define a hot spot as such a circle with many grains of salt. If
we have a big table, divide it into 4 unequal regions and sprinkle the salt evenly on the table,
then the probability of at least one hot spot in a region is roughly proportional to the area of
the region (as long as NP < < 1 where N is the number of nonoverlapping circles blanketing
the region). In order for the probability to not be proportional to the size of the region, the
salt must be sprinkled unevenly. The table represents the breast. The four unequal regions
represent the four quadrants of the breast. The grains of salt represent the microvessels in a
cross section of tissue. The center of the circle represents the tumor location.
Mathematically, suppose we define a hot spot as a circle of radius R that contains at
least n microvessels. Then N=A/(πR2) is the number of non-overlapping circles (regard-
less of whether they are a hot spot) that can blanket an area A. (Note that N may not be
an integer.) Let P be the probability that a circle is a hot spot. Then (1 – P) is the probabil-
ity that a circle is not a hot spot. (1 – P)N is the probability that there are no hot spots in
N circles. Q = 1 - (1 – P)N is the probability that there is at least one hot spot in N circles.
Thus, Q ≈NP ∝AP if NP < < 1. A plot of Q versus NP is shown in Fig. 3.
As a simple example, suppose a two dimensional cross-section of breast tissue
has microvessels distributed according to a Poisson distribution. Then the probabil-
ity pm(R,i) that there are m microvessels in a circle of radius R in the ith region of
the breast is given by the Poisson distribution: pm R; ið Þ ¼ mh ii=m!
 
e‐ mh ii where 〈m〉
i = ρ(i)πR
2 is the average number of microvessels in a circle of radius R and ρ(i) is
the areal density of microvessels in the ith region of the breast. We divide the
breast into five regions: the upper outer quadrant (UOQ), the upper inner quad-
rant (UIQ), the lower outer quadrant (LOQ), the lower inner quadrant (LIQ), and
the areolar region (AR). Then the probability qn(R,i) that there are at least n
microvessels in a circle of radius R is given by
qn R; ið Þ ¼ 1‐
Xn‐1
m¼0
pm R; ið Þ ð1Þ
To relate this to the notation above, if we define a hot spot as a circle of radius R0
with at least n0 microvessels, then the probability P that a circle is a hot spot is P ¼ qn0
R0; ið Þ . So the probability Q(i) that there is at least one hot spot in the ith region is
given by
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Q ið Þ ¼ 1‐ 1‐qn0 R0; ið Þ
 N ið Þ ð2Þ
where N(i) = A(i)/πR0
2 is the number of circles that fit in the area A(i) of the
ith region. (Note that N(i) may not be an integer.)
P
i¼1
5
A ið Þ ¼ AT where AT is the
total area of a cross section of the breast. Once we obtain Q(i), we normalize it
by the sum over Q(i) to obtain the fractional probabilities Qf(i) that there is at
least one hot spot in the ith region: Qf ið Þ ¼ Q ið Þ=
P
i¼1
5
Q ið Þ.
We modulated the density of microvessels in each region of the breast using
infrared measurements of the total (both oxygenated and deoxygenated) mean
hemoglobin concentration in the various breast regions for postmenopausal
women (Shah et al., 2004). To calculate the microvessel density modulation factor
f(i) for the ith region, we do the following. Let h(i) be the total mean hemoglobin
concentration measured in the ith region. We estimated the hemoglobin mass
mh(i) in the ith region using mh(i) = h(i) Vb b(i) where Vb is the volume of the
tissue in the entire breast, and b(i) is the fraction of tissue in the ith region of
the breast. The total breast volume Vb will cancel out later so its value does not
matter. The total hemoglobin mass Mh in the breast is MT ¼
X
i
mh ið Þ . The
mass fraction Fh of hemoglobin in the ith region is Fh(i) =mh(i)/MT. We take the
ratio the hemoglobin mass fraction to the breast tissue fraction to get f(i), the
microvessel density modulation factor: f(i) = Fh(i)/b(i). The microvessel density
ρ(i) in the ith region is given by ρ(i) = f(i)ρ0 where ρ0 is the measured areal dens-
ity of microvessels. Measurements of the 2D density ρ0 of microvessels in breast
Fig. 3 Plot of Q vs the product NP of the number N of trials and the probability P. Note that Q ~ NP for
NP < < 1 and Q ~ 1 for NP > > 1. The crossover occurs for NP ~1. Note that the number N of circles filling
the region is proportional to the area A of the region. For this plot we used P = 1%
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tissue have found values of 1 microvessel/mm2 (Carpenter et al., 2011) and 61
microvessels/mm2 (El-Gohary et al., 2009).
Results
Using the procedure described above, we have calculated the fractional probabilities for
at least one hot spot in the various regions of the breast assuming a Poisson distribu-
tion of microvessels in a 2D cross section of breast tissue. A hot spot was defined as a
circle of radius 200 μm with at least 5 microvessels. Our results are shown in Fig. 4
along with the observed tumor incidence (Morris & Kwong, 2004) from Fig. 2.
Notice that there is good agreement of the observed tumor incidence location in the
case of 1 microvessel/mm2 (Carpenter et al., 2011).
Parameter dependence
The sensitivity of our analysis to model parameters is implicitly contained in the equa-
tions. Human anatomy and physiology as well as experimental measurements restrict
many of the parameters to a rather narrow range, e.g., the radius of the breast, the frac-
tional amount of tissue in the quadrants of the breast, the variation in the total
Fig. 4 Comparison of the observed distribution of breast tumor locations from (Morris & Kwong, 2004) with
the fractional probability of at least one hot spot in the different regions of the breast assuming a Poisson
distribution of microvessels in 2D. In our simulation, the sampling circles had a radius of 200 μm. A hot spot
was defined as a sampling circle with at least 5 microvessels. The overall cross section of the breast was
assumed to be a circle with a radius of 7 cm. The fraction of tissue in the upper outer quadrant (UOQ),
upper inner quadrant (UIQ), lower outer quadrant (LOQ), lower inner quadrant (LIQ), and central (nipple)
region were assumed to be 0.38, 0.14, 0.24, 0.19, and 0.05, respectively. (Since the fraction of breast tissue in
the different regions of the breast has not been measured, these numbers are based on estimates from Dr.
Karen Lane, a breast surgeon at the University of California Irvine Medical Center.) To test our model, we
used the two published 2D mean microvessel densities of 1 (Carpenter et al., 2011) and 61 (El-Gohary et al.,
2009) microvessels/mm2. We modulated the microvessel density in various regions of the breast according
to the total hemoglobin concentration measured by near infrared diffuse optical spectroscopy in different
regions of the left breast of postmenopausal women (Shah et al., 2004), i.e., we used the following values
for the total hemoglobin: h(UOQ) = 16 μM, h(LOQ) = 12 μM, h(LIQ) = 13 μM, h(UIQ) = 15 μM,
and h(AR) = 19 μM
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hemoglobin in various regions of the breast, etc. We are free to choose the parameters
associated with our definition of a sampling circle and a hot spot. In the supplement
(Additional file 1), we show that our results are rather insensitive to the radius of a hot
spot and to the minimum number of microvessels in a hot spot as long as n ≥ 4. For n
< 4, it is easy to meet the requirements for a microvascular hot spot and there is a high
probability that every region of the breast will have at least one hot spot.
Discussion
Microvessel density and the oxygen diffusion length
We found good agreement between the observed tumor incidence location and the frac-
tional probability of hot spots for a density of 1 microvessel/mm2 (Carpenter et al., 2011).
However, this would imply a mean spacing of 1 mm between microvessels, a value that
seems slightly high if the oxygen diffusion length is 100 to 200 μm (Fidler et al., 2002;
Gray et al., 1953; Tannock, 1968; Brown & Giaccia, 1998; Thomlinson & Gray, 1955).
Keep in mind that the oxygen diffusing into a space between 2 microvessels covers about
200–400 μm. A microvessel density of 61 microvessels/mm2 (El-Gohary et al., 2009) cor-
responds to a mean spacing of 128 μm, which seems more consistent with 100 to 200 μm
as the oxygen diffusion length (see below), but leads to a high probability of a hot spot oc-
curring in each region with our definition of hot spots.
The values we used for the microvessel density were measured in breast tissue so
they are both physiologically realistic. However, although the value of 100 to 200 μm is
widely cited (Fidler et al., 2002; Gray et al., 1953; Tannock, 1968; Brown & Giaccia,
1998; Thomlinson & Gray, 1955), we know of no direct measurements of the diffusion
length of oxygen in living tissue. The values cited in the literature are inferred from in-
direct measurements. For example, Fidler et al. (Fidler et al., 2002) note that dividing
tumor cells tend to be within 75 μm of a blood vessel while apoptotic cells in a tumor
are twice as far (160–170 μm) from a blood vessel. Earlier researchers reported that
non-necrotic cells in corded tumors (i.e., tumors in the shape of a solid rod) were never
further than 100–200 μm from a blood vessel (Thomlinson & Gray, 1955). However,
these indirect measurements assume that oxygen is the limiting factor whereas lack of
an essential nutrient like glucose or the accumulation of high concentrations of lactic
acid could result in necrosis (Thomlinson & Gray, 1955). In addition, the microvessel
density varies from organ to organ due to the differing oxygen demands of different
types of cells and tissues. For example, fat does not need as much oxygen as muscle.
The need for measurements of the microvessel density distribution and fraction of breast
tissue in various regions
The simple example above assumed a Poisson distribution, but this is not a crucial as-
sumption. Indeed, there is no reason to believe that the Poisson distribution is the actual
microvessel density distribution. Other spatial distributions of the microvasculature could
also give the observed tumor incidence. That is why it would be useful to measure the
microvessel density distribution in all five regions for both 2D and 3D in normal breast
tissue obtained from autopsies and prophylactic mastectomies as well as breast reduction
surgery. It is important to use normal breast tissue that has not been remodeled by prolif-
erating neoplastic tissue. For 2D tissue slices, the blood vessels could be stained and then
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one could count the number of blood vessels in a series of non-overlapping circles to ob-
tain a histogram of the density distribution in units of number of microvessels per unit
area, e.g., per square mm. The radii of the circles could be comparable to the oxygen dif-
fusion length.
The 3D microvessel density is defined as the length of microvessels per unit volume.
Imagine having a 3D vascular network and filling the space with nonoverlapping sam-
pling spheres. The microvessel density equals the length of microvessels inside a sphere
divided by the volume of the sphere. A map of the 3D vascular network in breast tissue
has never been conducted because of the prohibitive cost of examining a z-stack of 5-
μm thick tissue slices using traditional methods. However, it should be possible to map
out the 3D vascular structure using advanced optical methods similar to those that
have been used to map out a cubic millimeter of the 3D angioarchitecture of the mur-
ine vibrissa cortex (Blinder et al., 2013).
We made estimates of the fraction of tissue in each of the 4 quadrants and in the nip-
ple/areolar/central region because this has not been previously measured. However,
measurements can and should be done on disease-free human specimens using tissue
from prophylactic mastectomies and autopsies. Images from breast magnetic resonance
imaging (MRI) are another way to determine the fraction of tissue in different quad-
rants. Patients undergoing a breast MRI lie prone with their breasts hanging in a pen-
dulous fashion. However, in MRI images, it is sometimes difficult to know exactly
where to delineate the boundary between the different quadrants since patients may be
slightly tilted, e.g., because they lean more on one elbow than the other.
Modulation of microvessel density
We modulated the density of microvessels in each region of the breast using infrared
measurements of the total mean hemoglobin concentration in the various breast re-
gions for postmenopausal women (Shah et al., 2004). The total hemoglobin measured
using near infrared imaging is in both capillaries and larger blood vessels. (Note that
oxygen diffuses out of both capillaries as well as pre-capillary vessels (arterioles) (Pitt-
man, 2011). This is why we refer to microvessels rather than capillaries.) In our calcula-
tion we do not need to assume that the total hemoglobin is contained entirely in the
microvessels. Rather we just assumed that the region-to-region variation of the micro-
vessel density is mirrored in the spatial modulation of the total hemoglobin.
Previous hypotheses for increased breast tumor incidence in UOQ are problematic
There have been a number of other hypotheses to explain why the preponderance of
breast tumors are found in the upper outer quadrant. These include the following:
[A] Distribution of breast tissue mass: The conventional wisdom is that there are
more tumors in the upper outer quadrant because there is more tissue in that
quadrant since the breast is shaped like a teardrop with axillary tissue under
the arm in the vicinity of the armpit (Haagensen, 1986; Lee, 2005). However,
our analysis indicates that if the 57% tumor incidence were random, this would
require 64% of the breast tissue to be in the upper outer quadrant, while
certainly less than half of the breast tissue is in the upper outer quadrant.
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Furthermore, it is not clear that bigger breasts have a higher risk of breast
cancer than smaller breasts (Jansen et al., 2014). Several studies find no
evidence that increased breast size is associated with increased risk of breast
cancer (Wynder et al., 1960; Katariya et al., 1974; Kolonel et al., 1986; Senie
et al., 1993; Koch et al., 2004), while others found indications of a positive
correlation (Scutt et al., 1997; Hsieh & Trichopoulos, 1991; Joensuu et al., 1992;
Kato et al., 1995). Still other studies found that women with smaller breasts
were at increased risk (Tavani et al., 1996; Thurfjell et al., 1996). It is worth
noting that compared to small breasts, large breasts tend to have more fat but a
comparable amount of fibroglandular tissue. (Fibroglandular tissue is where tumors
tend to start.) This is consistent with the fact that women with large breasts and small
breasts tend to produce the same amount of milk (Edgar, 2005).
[B] Food additives and environmental toxins: A higher incidence in the upper outer
quadrant has also been documented in third world countries, e.g., the upper outer
quadrant incidence is ~51% in India (Dinshaw et al., 2005), ~40% among West
Indian women in Trinidad (Raju & Naraynsingh, 1989), ~54% in Goiania in Brazil
(Nunes et al., 2011), ~30–48% in Nigeria (Adesunkanmi et al., 2006), and ~50%
between 1927 and 1946 in Costa Rica (De Girolami & Luros, 1958). These
percentages are all comparable to that found in the large study of California breast
cancer patients between 1988 and 1999 (Morris & Kwong, 2004). This implies that
modern food additives and environmental toxins cannot explain the higher tumor
incidence in the upper outer quadrant. Interestingly, the tumor incidence in the
UOQ in England and Wales has slowly been rising from 48% in 1979 to 53% in
2000 (Darbre, 2005).
[C] Deodorants and antiperspirants: It has been suggested that the aluminum salts in
underarm antiperspirants and deodorants can mimic estrogens and increase the risk
of cancer (Darbre & Charles, 2010), but there is no real evidence to support this
and it has largely been discounted (Namer et al., 2008). In addition, the higher
tumor incidence in the UOQ in third world countries (Dinshaw et al., 2005; Raju &
Naraynsingh, 1989; Nunes et al., 2011; Adesunkanmi et al., 2006; De Girolami &
Luros, 1958) and between 1927 and 1946 in Costa Rica (De Girolami & Luros,
1958) implies that deodorants and antiperspirants are not the cause. Furthermore,
in mammals other than humans, spontaneous mammary tumors are most likely to
occur near the legs. (Spontaneous mammary tumors refer to those not caused
artificially, e.g., by introducing by a virus.) In dogs, 40–60% of mammary tumors
occur in the pair of glands located most caudally, i.e., near the hind legs (Bostock,
1975; Cotchin, 1958; Fidler & Brodey, 1967; Cotchin, 1957; Huggins & Moulder,
1944). In cats (Cotchin, 1957; Hayden & Nielsen, 1971) and mice (Prehn et al.,
1954; Pullinger, 1952), most spontaneous mammary tumors occur in the anterior
mammary glands, i.e., those closest to the front legs. Most tumors in female rats are
benign mammary tumors, and the most common locations of these tumors are in
the armpits and in the belly or groin area (Ducummon, 1995). Since the use of
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antiperspirants and deodorants cannot explain the higher incidence of spontaneous
tumors in the mammary glands near the limbs of mammals (Bostock, 1975;
Cotchin, 1958; Fidler & Brodey, 1967; Cotchin, 1957; Huggins & Moulder, 1944;
Hayden & Nielsen, 1971; Prehn et al., 1954; Pullinger, 1952), this is unlikely to be
the explanation.
[D] Mechanical motion: The upper outer quadrant is closer to the arms and
shoulders. Furthermore, as we mentioned above, spontaneous tumors in other
mammals tend to occur near the limbs (Bostock, 1975; Cotchin, 1958; Fidler &
Brodey, 1967; Cotchin, 1957; Huggins & Moulder, 1944; Hayden & Nielsen,
1971; Prehn et al., 1954; Pullinger, 1952). So one might wonder whether arm
motion could be linked to breast cancer. However, we do not believe that arm
motion is a risk factor because, to the best of our knowledge, there does not
appear to be any dorsal-ventral asymmetry in the occurrence of breast tumors,
i.e., there does not seem to be any increased tumor incidence near (or far
from) the chest wall muscles.
[E] Temperature: One might argue that the upper outer quadrant is near the
armpit which is warmer other parts of the body. However, temperature does
not appear to be a factor. Infrared imaging measurements indicate that the
upper outer quadrant is neither hotter nor colder than the three other
quadrants (Head et al., 2001).
[F] Lymph: The lymph system can be thought of as a sewage system for the cells,
though it is also a crucial component of the immune system. Cells dump waste
products into the surrounding interstitial fluid which is mostly taken up by the venous
system with a few percent taken up by the lymph microvessels as lymph fluid. One
might be concerned that the toxins and waste products in the lymph could be
carcinogenic. In most women, all the areas of the breast drain through the lymph
vessels in the upper outer quadrant to the axillary lymph nodes under the arm, and to
a lesser extent to the lymph nodes in the internal mammary chain along the sternum
(Estourgie et al., 2004; Suami et al., 2008). Lymph drainage through the upper outer
quadrant may mean that there is a higher concentration of waste products in this
quadrant, but it is not clear how this drainage could adversely affect mammary
epithelial cells and other cells outside of the lymph vessels. (As an analogy, the sewage
system in your home does not affect your health as long as the sewage stays in the
sewage pipes.) Furthermore, ductal carcinoma in situ (DCIS) and lobular carcinoma in
situ (LCIS) only involve the lymph system in 1–2% of cases (Wax, 2012), and yet both
DCIS and LCIS occur more often in the upper outer quadrant than anywhere else
(Morris & Kwong, 2004). (Recall that DCIS and LCIS are confined within the milk
ducts and lobules, and have not broken through the basement membrane. So the
abnormal cells associated with DCIS and LCIS are not in contact with lymph fluid
that is confined in lymph vessels.)
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Implications
If our hypothesis is correct, then this means that the regions with a high density of
microvessels are at a greater risk of developing tumors. This would apply not just to
breast cancer but to other organs as well. Microvascular hot spots would also increase
the risk of being sites of metastasis. This may explain why tumors that metastasize to
the breast from an extramammary primary tumor elsewhere in the body preferentially
occur in the upper outer quadrant (Toombs & Kalisher, 1977; Lee et al., 2010) with an
UOQ incidence of about 66% (Toombs & Kalisher, 1977).
If our hypothesis that tumors are prone to form where there are microvascular hot
spots proves true, then there could be important clinical implications. For example, it
might help to explain why wounding the cellular microenvironment promotes tumori-
genesis (Dolberg & Bissell, 1984). While wounding promotes inflammation and inflam-
mation is known to increase cancer risk (Coussens & Werb, 2002), the remodeling of
the vasculature during healing could produce microvascular hot spots that would also
promote tumor recurrence. This could help to explain the peak in cancer relapses
within 2 to 3 years after resection of tumors in breast (Retsky et al., 2012), prostate
(Hanin & Zaider, 2011; Weckermann et al., 2009), lung (Demicheli et al., 2012) and
pancreatic (Deylgat et al., 2011) cancers as well as osteosarcoma (Tsunemi et al., 2003)
and melanoma (Tseng et al., 2009). If microvascular hot spots increase the risk of re-
currence of cancer, then perhaps therapeutics could be found to prevent the formation
of microvascular hot spots during wound healing after surgery. In the case of breast
cancer a small clinical study has shown that one-time perioperative use of the non-
steroidal anti-inflammatory drug (NSAID) ketorolac cuts the risk for early recurrence
by half (Retsky et al., 2012; Forget et al., 2010). This could be due to a reduction in the
inflammatory response and/or in the regrowth of vasculature without generation of
microvascular hot spots.
Diffuse optical spectroscopic imaging could identify hot spots
Infrared imaging in the form of Diffuse Optical Spectroscopic Imaging (DOSI) could be
used to identify microvascular hot spots and hence, patients and regions with a higher
risk of cancer. This technique uses diffuse scattering of near-infrared light to assess the
local concentrations of metabolites such as oxygenated and deoxygenated hemoglobin
with a spatial resolution of approximately 1 cm (Shah et al., 2001; Cerussi et al., 2001;
O'Sullivan et al., 2013). Hand-held DOSI scanning devices have been developed to per-
form whole breast scanning of normal breast tissue (Tromberg et al., 2016). If imaging
techniques such as DOSI could identify hot spot regions at high risk for breast cancer,
then local treatment could be applied to minimize risk. For example, milk ducts
could be ablated in these hot spot regions using breast-conserving prophylactic
intraductal therapy. In this therapeutic approach, selected agents are injected into
designated ducts, resulting in extensive destruction of mammary epithelial cells
(Murata et al., 2006; Stearns et al., 2011).
Application of hypothesis to tumors in other organs
While we believe that our hypothesis of microvascular hot spots can be applied to tu-
mors in other organs, we are not able to apply our simulation to other types of tumors
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due to a lack of data on the spatial distribution of blood flow in other organs. The per-
fusion data (Shah et al., 2004) that we used for the breast was obtained with near infra-
red diffuse optical spectroscopy (Shah et al., 2001; Cerussi et al., 2001). Infrared
radiation can penetrate a small distance below the skin, making the blood flow in the
breast is accessible but this is not practical for organs such as the colon, lungs, etc.
Conclusions
Although tumor location is viewed as random, the statistics of the anatomical location
of tumors in organs such as the breasts, lungs, colon and fallopian tubes/ovaries indi-
cate a preference for some anatomical regions over others. The question of why a
tumor occurs where it does in an organ cannot be addressed solely in terms of genetics
or environmental factors, implying that there is another risk factor for cancer that is
not appreciated.
Our hypothesis is that tumors tend to occur at ‘microvascular hot spots’ where there
is an unusually high microvessel density in normal tissue. These microvessels would
supply ample oxygen and nutrients to a budding tumor, as well as have receptors for
factors that promote angiogenesis such as VEGF. In this paper we focused on breast
cancer and the observation that about 60% of breast tumors occur in the upper outer
quadrant (Morris & Kwong, 2004) even though the upper outer quadrant comprises
only 35–40% of the breast tissue.
To demonstrate the plausibility of our hypothesis, we did a calculation to estimate
the fractional probability that there is at least one microvascular hot spot in each region
of the breast assuming a Poisson distribution of microvessels in 2D cross sections of
breast tissue. We modulated the microvessel density in various regions of the breast ac-
cording to the total hemoglobin concentration measured by near infrared diffuse op-
tical spectroscopy in different regions of the breast of postmenopausal women (Shah
et al., 2004). For a mean microvessel density of 1 microvessel/mm2 (Carpenter et al.,
2011), we find good agreement of the fractional probability of at least one hot spot with
the observed invasive tumor occurrence (Morris & Kwong, 2004) in different regions of
the breast. Of course, there is no reason to believe that microvessels have a Poisson dis-
tribution, and much work needs to be done to measure the microvessel density distri-
bution as well as the fraction of breast tissue in different regions of the breast.
If our hypothesis that tumors are prone to form where there are microvascular hot
spots proves true, it might help to explain explain why wounding the cellular micro-
environment promotes tumorigenesis (Dolberg & Bissell, 1984) and why cancer recur-
rence is highest in the first 2 to 3 years after tumor resection (Retsky et al., 2012;
Hanin & Zaider, 2011; Weckermann et al., 2009; Demicheli et al., 2012; Deylgat et al.,
2011; Tsunemi et al., 2003; Tseng et al., 2009). While inflammation is associated with
wound healing and is known to increase cancer risk (Coussens & Werb, 2002), the re-
modeling of the vasculature during healing could produce microvascular hot spots that
could also promote tumor recurrence. If hot spots are a risk factor, then near infrared
imaging such as DOSI could be used to identify hot spots and prophylactic measures
could be implemented.
In summary, our paper is largely speculative. Our goal has not been to solve a prob-
lem, but rather to point out that there is an important problem that has largely been ig-
nored. Namely, that tumor location in an organ is not entirely random, indicating that
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there are cancer risk factors that have largely been ignored. Our hope is that much
more research will be done to understand why tumors occur where they do.
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